Dr Dirk Geerts
Dr Dirk Geerts
Ph.D.
Academic Medical Center - University of Amsterdam
Senior Scientist
Amsterdam, NH, Netherlands

Academics versus Pharma

More and more biomedical research is performed by pharmaceutical companies, and more and more academic results are followed up by spin-off companies or in collaboration with pharma companies. Yet, for instance with hiring, both academia and pharma seem to believe there is still an "Iron curtain" in between. - Is this true? - Is this desirable, and if not, what could we do to tear down the wall?
Erick Wesley Hedima
Erick Wesley Hedima
Ministry of Health, Yola, Nigeria
Pharmacist
Yola, Adamawa, Nigeria
2 days ago
It will be great if biomedical research would be conducted by both academia and the Pharmaceutical giants that in itself will reduce the risk of biases since "most Pharma giants seem to go for product promotion". The collaboration should be encouraged because it'll mean well for research.
Ismail Temitayo Gbadamosi
Ismail Temitayo Gbadamosi
College of Health Sciences
Mr
Ilorin, Kwara State, Nigeria
2 days ago
Well, it is not exactly desirable. One way to combat issues like this is to continuously support the culture of interdisciplinary research so there will be an avenue to gain insights to relevant skillset that may be required of you during an interview.
Norbert Nwankwo
Norbert Nwankwo
Madonna University
Elele, Rivers, Nigeria
2 days ago
Genuine collaboration with and good intentions for the source of the know-how or knowledge (academia) may be lacking. It is easier and better to buy an IP from an academia than attempt other ways. It is usually disastrous when it backfires.
More IPs may come from same academia if absorbed by the company.
Dr. Robert Rahimi
Dr. Robert Rahimi
MD, MSCR
Baylor University Medical Center
Assistant Professor
Dallas, Texas, United States
4 days ago
Difficult question to give a simple answer. The researcher has to determine what is best for themselves and their family and what drives them to be successful as everyone's situation is different. Go with your gut.
Mr. Ajay Kumar
Mr. Ajay Kumar
PhD
Himachal Pradesh University
Shimla, Himachal Pradesh, India
4 days ago
Ther academia and pharma work together and publish mutually.
Dr. Ebrahim Mohammadi Goltapeh
Dr. Ebrahim Mohammadi Goltapeh
Tarbiat Modares University
Professor
Tehran, Tehran, Iran (Islamic Republic of)
4 days ago
Dear Dr.Dirk Geerts With due regards, This hard and Iron walls between Researchers and Companies needs to be more and more collaboration so that Lab. to Research and Research to Nationalities to lab. so that feedback should be fully complete.Money is sweet and very testy so......it is very difficult to leave it? So in any work we should see the presence of the God.
Sandra Bedrosian Sermone
Sandra Bedrosian Sermone
GePs
ADNP-kids Research Foundation
Founder
Brush Prairie, WA, United States
4 days ago
Big pharma can fund the research and benefit the most vs academics. But the rare disease side suffers because they are only researching what they can profit from.
Mirjana Zlatkovic-Svenda
Mirjana Zlatkovic-Svenda
Institute of Rheumatology
Ass Prof, MD, PhD
Beograd, Srbija, Yugoslavia
5 days ago
There is no iron curtain, academia and pharma work together and publish mutually.